Instalab

Pistachio (Pis v 1) IgE Test Blood

The clearest blood signal of true pistachio allergy, beyond what a standard nut test can confirm.

Should you take a Pistachio (Pis v 1) IgE test?

This test is most useful if any of these apply to you.

Reacted to Cashew or Pistachio
You reacted after eating one of these nuts and want to know if your immune system is targeting the high-risk storage protein.
Parents of a Nut-Allergic Child
Your child has known nut sensitization and you want to know which nuts carry real risk versus which positive tests reflect cross-reactivity.
Broad Nut Sensitization on Panels
You tested positive to multiple nuts on a standard panel and need component testing to sort genuine allergies from harmless cross-reactivity.
Tracking Toward Reintroduction
You're working with an allergist on supervised pistachio reintroduction and want to track whether antibody levels are trending downward.

About Pistachio (Pis v 1) IgE

If you or your child has reacted to pistachio or cashew, or you have a broad nut sensitization picture that nobody has been able to sort out, this test answers a specific question: is the immune system targeting the part of pistachio most tied to real, sometimes severe reactions? A standard pistachio extract test can flag sensitization, but it often cannot tell you whether that sensitization will translate into a real-world reaction.

Pis v 1 is a 2S albumin, a type of seed storage protein found in pistachio. It is recognized as a major pistachio allergen because antibodies against it tend to track with clinical allergy more reliably than antibodies to the whole nut, which is why component-level testing has become an important tool for sorting genuine pistachio allergy from harmless cross-reactivity.

What Pis v 1 Antibodies Actually Reveal

Your immune system can make a class of antibody called IgE (immunoglobulin E) against foods it has decided to treat as threats. When IgE attaches to specific proteins, it can trigger the cells that drive allergic reactions, from hives to anaphylaxis. This test measures IgE that specifically recognizes Pis v 1, one of five identified pistachio allergens (Pis v 1 through Pis v 5).

Pis v 1 belongs to a family of plant storage proteins called 2S albumins. These proteins are physically tough. They survive heat and digestion, which is part of why allergies driven by them tend to produce systemic, sometimes severe reactions rather than mild mouth-only symptoms. In one study, IgE from 19 of 28 pistachio-allergic patients bound to native Pis v 1, supporting its classification as a major pistachio allergen.

How This Differs From a Standard Pistachio Test

A whole-extract pistachio IgE test mixes together all the proteins in the nut, including some that cross-react with pollen or other plant proteins and produce positive readings without causing real allergy. A component test like Pis v 1 isolates the single protein most tied to clinical reactivity. The trade-off is well documented: extract tests catch more sensitization (higher sensitivity) but generate more false alarms, while component tests are more specific for true allergy.

In a study of 169 nut-allergic children tested with a multiplex component array, Pis v 1 IgE at 1.0 kU/L or higher gave the highest overall diagnostic accuracy for pistachio reactivity, and very high levels (15 kU/L or above) reached 100% specificity and positive predictive value for clinical reactivity in the cashew-pistachio cluster. More than 93% of clinically reactive children had Pis v 1 (or the closely related cashew protein Ana o 3) at 0.3 kU/L or above.

The Cashew Connection

Pistachio and cashew share a strong, biologically anchored link. Pis v 1 shares roughly 66% of its amino acid sequence with Ana o 3, the equivalent storage protein in cashew. In serum testing, cashew and pistachio IgE levels track together so closely (correlation coefficient around 0.98, where 1.0 would be a perfect match) that clinicians describe a single cashew-pistachio allergic pattern.

In one cohort, 98% of children sensitized to cashew were also sensitized to pistachio, though only about a third actually reacted to pistachio when tested. That gap matters. It means a positive extract test alone overcalls pistachio allergy, and component testing helps separate the truly allergic from the merely cross-sensitized.

Risk of Severe Reactions

Storage proteins like Pis v 1 are the proteins most consistently associated with systemic allergic reactions, including anaphylaxis. In multiplex profiling, Pis v 1 clusters with other 2S albumins across nuts (Ana o 3 in cashew, Cor a 14 in hazelnut, Jug r 1 in walnut), and this cluster is the one tied to the most severe, persistent food allergies.

By contrast, sensitization driven by pollen-cross-reactive proteins (a different family called PR-10) tends to produce milder, often mouth-limited symptoms and lower risk of serious reactions. Knowing which type of pistachio sensitization is at play is the practical difference between strict avoidance with an epinephrine auto-injector and a more measured, supervised reintroduction strategy.

How One Reading Should Be Interpreted

IgE testing is best read as part of a picture, not a verdict. Even a high Pis v 1 level does not prove clinical allergy on its own, and a low level does not entirely rule it out. Among children sensitized to pistachio by skin or extract testing, 31% failed an oral food challenge, and 75% of those who failed had pistachio extract IgE below 2 kU/L. A small share of clinically allergic patients have extract IgE below the usual positive cutoff entirely.

Component testing tightens the picture but does not replace clinical judgment. Higher Pis v 1 levels (above about 1 kU/L) raise the pre-test probability of true allergy considerably, and very high levels (above 15 kU/L) make a positive oral food challenge nearly certain in the populations studied. Lower positive results indicate sensitization that may or may not be clinically meaningful.

Tracking Your Trend

A single IgE value is a snapshot, not a forecast. Tree nut allergies tend to persist into adulthood more than milk or egg allergies, but levels do shift over time, and a falling Pis v 1 trend is one of the signals clinicians use when considering whether a supervised reintroduction is safe to attempt.

If your baseline shows clear Pis v 1 sensitization, retesting at six to twelve months while strictly avoiding pistachio and cashew gives you a real trajectory rather than a single data point. If you are working with an allergist on immunotherapy or considering a food challenge, more frequent monitoring is appropriate. A meaningful change is a sustained drop across multiple readings, not a single fluctuation.

What to Do With an Unexpected Result

A positive Pis v 1 result in someone who has never knowingly eaten pistachio or cashew should not lead to a casual food trial. Bring the result to an allergist who can combine it with skin prick testing, history, and, when needed, a supervised oral food challenge. The challenge remains the gold standard when the picture is ambiguous.

If Pis v 1 IgE is high alongside positive Ana o 3 (cashew 2S albumin), expect strict avoidance of both nuts and an epinephrine auto-injector prescription. If Pis v 1 is low or negative but a whole-extract pistachio test is positive, the most likely explanation is cross-reactive sensitization rather than true allergy, and an allergist may consider a supervised challenge. Consider asking your allergist about basophil activation testing, a functional blood test that can add specificity in unclear cases.

Where This Test Fits in a Broader Workup

Pis v 1 IgE rarely stands alone. The most useful workup pairs it with the cashew component Ana o 3 and with whole-extract pistachio and cashew IgE. Together these tell you whether you are dealing with storage-protein-driven allergy (higher risk) or a milder cross-reactive pattern. Skin prick testing adds another data point, and concordance between skin testing and blood IgE for pistachio is only moderate, which is why both are often run.

For someone with broader nut sensitization, expanding to walnut (Jug r 1), hazelnut (Cor a 14), and peanut (Ara h 2) components builds a map of which nuts are most likely to cause real reactions and which may be safe to attempt under medical supervision.

What Moves This Biomarker

Evidence-backed interventions that affect your Pistachio (Pis v 1) IgE level

Decrease
Omalizumab combined with oral immunotherapy
Adding omalizumab, an anti-IgE antibody injection, to food oral immunotherapy raises the dose of allergen you can tolerate and reduces reactions during the dosing phase. A meta-analysis of randomized trials in children with IgE-mediated food allergy found significant improvements in desensitization rates and safety. This combination is used in specialty allergy clinics for multi-food or high-risk patients.
MedicationStrong Evidence
Decrease
Omalizumab alone
Omalizumab binds free IgE and reduces allergic reactivity. In a randomized trial of 180 participants with peanut and other food allergies, 16 weeks of omalizumab raised the reaction threshold for peanut and other common food allergens compared to placebo, in participants as young as one year old. Tree nuts including pistachio were among the allergens covered. The protection lasts only while you are receiving the injections.
MedicationStrong Evidence
Decrease
Cashew oral immunotherapy
Gradually eating increasing doses of cashew protein under medical supervision can desensitize you to both cashew and pistachio. In a study of 65 cashew-allergic patients, cashew oral immunotherapy desensitized most participants and produced cross-desensitization to pistachio, reflecting the shared 2S albumin biology. This is a clinic-supervised protocol, not something to attempt independently, because reactions during dosing are common.
MedicationModerate Evidence
Decrease
Strict avoidance of pistachio and cashew
Avoiding the allergen does not directly suppress IgE production, but ongoing accidental exposures can keep IgE levels elevated. Strict avoidance is the foundational management strategy for tree nut allergy across clinical guidelines, and tree nut allergies do resolve in 9% to 14% of cases over time, with falling IgE often preceding resolution. Carrying epinephrine remains essential because cross-contamination is hard to fully prevent.
LifestyleModest Evidence

Frequently Asked Questions

References

14 studies
  1. Costa J, Silva I, Vicente AA, Oliveira M, Mafra ICritical Reviews in Food Science and Nutrition2019
  2. Perry T, Matsui EC, Conover-walker MK, Wood RAJournal of Allergy and Clinical Immunology2008